期刊文献+
共找到10篇文章
< 1 >
每页显示 20 50 100
输入供体血对延长大鼠移植胰腺功能存活的初步研究 被引量:1
1
作者 孙治君 姚榛祥 《中国普外基础与临床杂志》 CAS 2001年第6期364-366,共3页
目的 探索供体血输入同种大鼠对诱导胰腺移植耐受的可能性。方法 用雄性Wistar大鼠作为实验的供受体 ,胰腺移植当天取供体大鼠全血 1ml ,注入糖尿病受体大鼠腹腔 ,辅以短期的硫唑嘌呤 (Aza)。结果 移植胰腺功能存活时间为 2 8~ 112... 目的 探索供体血输入同种大鼠对诱导胰腺移植耐受的可能性。方法 用雄性Wistar大鼠作为实验的供受体 ,胰腺移植当天取供体大鼠全血 1ml ,注入糖尿病受体大鼠腹腔 ,辅以短期的硫唑嘌呤 (Aza)。结果 移植胰腺功能存活时间为 2 8~ 112天 (平均 64 .2天 ) ,与单纯用硫唑嘌呤组 ( 10 .2天 )或单纯输入供体血液组 ( 9.8天 )相比 ,移植胰腺功能存活时间显著延长 (P<0 .0 1)。结论 移植前短期使用免疫抑制剂以及移植当天输入供体血液 ,能延长大鼠移植胰腺功能存活时间。 展开更多
关键词 大鼠 供体血 胰腺移植 功能存活
下载PDF
同种胰节段移植有功能存活九个月以上一例报告
2
作者 陈实 夏穗生 +6 位作者 唐锦治 覃修福 顾相君 谢复东 明长生 王莺 周平 《中华器官移植杂志》 CAS 1985年第2期50-52,共3页
关键词 同种 移植 功能存活
原文传递
胰岛移植实验研究系列
3
作者 王吉甫 詹文华 《医学研究杂志》 1993年第5期19-21,共3页
本系列包括四个分课题的研究,现分述如下: 1.
关键词 胰岛移植 胰岛细胞 鼠糖尿病 诱导免疫耐受 糖尿病模型 细胞融合 功能存活 存活时间 大鼠 密度梯度离心
下载PDF
Ad-CTLA-4Ig基因导入对胰十二指肠移植大鼠免疫耐受的实验研究 被引量:2
4
作者 孟令祥 胡伟明 +4 位作者 张肇达 韩方海 周祥 贾巍 陆慧敏 《四川大学学报(医学版)》 CAS CSCD 北大核心 2007年第3期374-377,共4页
目的研究基因转导法导入细胞毒性T淋巴细胞相关抗原-4融合蛋白基因(CTLA-4Ig)对诱导大鼠胰腺移植免疫耐受的作用。方法采用链脲霉素60mg/kg尾静脉一次性注射法诱导建立Wistar大鼠型糖尿病模型。以SD大鼠为供体,糖尿病Wistar大鼠为受体,... 目的研究基因转导法导入细胞毒性T淋巴细胞相关抗原-4融合蛋白基因(CTLA-4Ig)对诱导大鼠胰腺移植免疫耐受的作用。方法采用链脲霉素60mg/kg尾静脉一次性注射法诱导建立Wistar大鼠型糖尿病模型。以SD大鼠为供体,糖尿病Wistar大鼠为受体,用体外低温保存状态下对供器官行腺病毒介导CTLA-4Ig基因转导制作异基因大鼠胰十二指肠移植动物模型。术后监测血糖,记录大鼠功能性存活期。术后3、10、17、28d经大鼠眶后静脉取血,应用ELISA法检测血清IL-2表达,Western blot检测人CTLA-4Ig的蛋白表达。结果对照组大鼠功能性存活期为(11±1)d,转导组功能性存活期为(33±4)d(P<0.01);对照组大鼠术后血清中未检测到人CTLA-4Ig蛋白表达,所有转导组存活病例,第10d血清中均有人CTLA-4Ig表达;转导组术后第3d、第10d血清IL-2分别为(33.710±7.803)pg/mL、(47.846±14.050)pg/mL,小于对照组(P<0.01)。结论体外低温保存状态下对供器官行腺病毒介导人CTLA-4Ig基因转导,可以延长大鼠胰十二指肠移植术后功能性存活期,诱导免疫耐受。 展开更多
关键词 胰十二指肠移植 细胞毒性T淋巴细胞相关抗原-4融合蛋白重组腺病毒(Ad-CTLA-4Ig) 免疫 耐受 IL-2 功能存活
下载PDF
Treatment of advanced rectal cancer after renal transplantation 被引量:2
5
作者 Hai-Yi Liu Xiao-Bo Liang Yao-Ping Li Yi Feng Dong-Bo Liu Wen-Da Wang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第15期2058-2060,共3页
Renal transplantation is a standard procedure for endstage renal disease today. Due to immunosuppressive drugs and increasing survival time after renal transplantation, patients with transplanted kidneys carry an incr... Renal transplantation is a standard procedure for endstage renal disease today. Due to immunosuppressive drugs and increasing survival time after renal transplantation, patients with transplanted kidneys carry an increased risk of developing malignant tumors. In this case report, 3 patients with advanced rectal cancer after renal transplantation for renal failure were treated with anterior resection or abdominoperineal resection plus total mesorectal excision, followed by adjuvant chemotherapy. One patient eventually died of metastasized cancer 31 mo after therapy, although his organ grafts functioned well until his death. The other 2 patients were well during the 8 and 21 mo followup periods after rectal resection. We therefore strongly argue that patients with advanced rectal cancer should receive standard oncology treatment, including operation and adjuvant treatment after renal transplantation. Colorectal cancer screening in such patients appears justified. 展开更多
关键词 Rectal cancer Renal transplantation Endstage renal disease TREATMENT SCREENING
下载PDF
Chronic bile duct hyperplasia is a chronic graft dysfunction following liver transplantation 被引量:4
6
作者 Jian-Wen Jiang Zhi-Gang Ren +3 位作者 Guang-Ying Cui Zhao Zhang Hai-Yang Xie Lin Zhou 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第10期1038-1047,共10页
AIM: To investigate pathological types and influential factors of chronic graft dysfunction (CGD) following liver transplantation (LT) in rats. METHODS: The whole experiment was divided into three groups: (1) Normal g... AIM: To investigate pathological types and influential factors of chronic graft dysfunction (CGD) following liver transplantation (LT) in rats. METHODS: The whole experiment was divided into three groups: (1) Normal group (n = 12): normal BN rats without any drug or operation; (2) SGT group (syngeneic transplant of BN-BN, n = 12): both donors and recipients were BN rats; and (3) AGT group (allogeneic transplant of LEW-BN, n = 12): Donors were Lewis and recipients were BN rats. In the AGT group, all recipients were subcutaneously injected by Cyclosporin A after LT. Survival time was observed for 1 year. All the dying rats were sampled, biliary tract tissues were performed bacterial culture and liver tissues for histological study. Twenty-one d after LT, 8 rats were selected randomly in each group for sampling. Blood samples from caudal veins were collected for measurements of plasma endotoxin, cytokines and metabonomic analysis, and faeces were analyzed for intestinal microflora. RESULTS: During the surgery of LT, no complications of blood vessels or bile duct happened, and all rats in each group were still alive in the next 2 wk. The long term observation revealed that a total of 8 rats in the SGT and AGT groups died of hepatic graft diseases, 5 rats in which died of chronic bile duct hyperplasia. Compared to the SGT and normal groups, survival ratio of rats significantly decreased in the AGT group (aP < 0.01, bP < 0.001, respectively). Moreover, liver necrosis, liver infection, and severe chronic bile duct hyperplasia were observed in the AGT group by H and E stain. On 21 d after LT, compared with the normal group (25.38 ± 7.09 ng/L) and SGT group (33.12 ± 10.26 ng/L), plasma endotoxin in the AGT group was remarkably increased (142.86 ± 30.85 ng/L) (both P < 0.01). Plasma tumor necrosis factor-α and interleukin-6 were also significantly elevated in the AGT group (593.6 ± 171.67 pg/mL, 323.8 ± 68.30 pg/mL) vs the normal (225.5 ± 72.07 pg/mL, 114.6 ± 36.67 pg/mL) and SGT groups (321.3 ± 88.47 pg/mL, 205.2 ± 53.06 pg/mL) (P < 0.01). Furthermore, Bacterial cultures of bile duct tissues revealed that the rats close to death from the SGT and AGT groups were strongly positive, while those from the normal group were negative. The analysis of intestinal microflora was performed. Compared to the normal group (7.98 ± 0.92, 8.90 ± 1.44) and SGT group (8.51 ± 0.46, 9.43 ± 0.69), the numbers of Enterococcus and Enterobacteria in the AGT group (8.76 ± 1.93, 10.18 ± 1.64) were significantly increased (both aP < 0.01, bP < 0.05, respectively). Meanwhile, compared to the normal group (9.62 ± 1.60, 9.93 ± 1.10) and SGT group (8.95 ± 0.04, 9.02 ± 1.14), the numbers of Bifidobacterium and Lactobacillus in the AGT group (7.83 ± 0.72, 8.87± 0.13) were remarkably reduced (both aP < 0.01, bP < 0.05, respectively). In addition, metabonomics analysis showed that metabolic profiles of plasma in rats in the AGT group were severe deviated from the normal and SGT groups. CONCLUSION: Chronic bile duct hyperplasia is a pathological type of CGD following LT in rats. The mechanism of this kind of CGD is associated with the alterations of inflammation, intestinal barrier function and microflora as well as plasma metabolic profiles. 展开更多
关键词 Liver transplantation Chronic graft dysfunction Chronic bile duct hyperplasia METABONOMICS Intestinal barrier function
下载PDF
平衡法心室核素显像对急性心肌梗死恢复期PTCA术的评价
7
作者 刘晓堃 赵碧琼 +3 位作者 尚小明 姜玉如 葛健 郭玉环 《中国煤炭工业医学杂志》 2002年第5期422-423,共2页
目的 应用99mTc平衡法心室核素显像 (ERNA)评价急性心肌梗死 (AMI)恢复期 (2~ 4周 )PTCA术对左心功能的影响。方法 选择 47例首次AMI患者分为PTCA组 2 1例 ,对照组 2 6例。在AMI后 2周内分别行冠状动脉造影、ERNA ,而后PTCA组患者在... 目的 应用99mTc平衡法心室核素显像 (ERNA)评价急性心肌梗死 (AMI)恢复期 (2~ 4周 )PTCA术对左心功能的影响。方法 选择 47例首次AMI患者分为PTCA组 2 1例 ,对照组 2 6例。在AMI后 2周内分别行冠状动脉造影、ERNA ,而后PTCA组患者在AMI后 2~ 4周内行PTCA/支架置入术 ,对照组行心肌梗死常规治疗。二组病例均在治疗后 8~ 1 2周复查ERNA。比较治疗前后左室射血分数、前 1 / 3射血分数、高峰射血率、高峰充盈率、前 1 / 3充盈分数、相角程及平均左室局部射血分数等参数的变化。结果 PTCA组术后与术前ERNA比较显示 ,左室收缩功能参数LEF、ArEF、1 / 3LEF、LPER较术前分别改善 (48.1 4± 5 .66 %vs 43 .71±6 .77% ,49.48± 5 .82 %vs 41 .86± 6 .0 1 % ,1 2 .33± 2 .69%vs 9.1 9± 3 .0 8% ,3 .1 9± 0 .45EDV/svs 2 .58± 0 .48EDV/s,P均 <0 .0 1 ) ,相角程较术前明显下降 (56 .1 4± 9.34°vs 60 .90± 1 2 .75° ,P <0 .0 5)。结论 AMI恢复期PTCA术安全可靠 ,可明显改善左心整体、局部收缩功能及心室收缩同步性 ,具有广泛应用性 ;ERNA评价PTCA术对AMI心功能的影响准确可靠 ,可作为监测AMI介入治疗疗效的重要手段。 展开更多
关键词 平衡法心室核素显像 经皮冠状动脉腔内成形术 急性心肌梗死 存活心肌心功能 放射性核素显像
下载PDF
肾移植受者蛋白尿发生机制及处理 被引量:1
8
作者 吴雄飞 《中华医学信息导报》 2007年第21期14-15,16,共3页
肾移植术后长期蛋白尿与普通慢性肾脏疾病一样,提示产生蛋白尿的有功能肾单位将会逐渐减少最终走向移植肾衰竭。蛋白尿影响移植肾长期有功能存活逐渐受到重视,关于肾移植受者蛋白尿有多个难题:①对于术前原肾尚有尿量伴有蛋白尿的患... 肾移植术后长期蛋白尿与普通慢性肾脏疾病一样,提示产生蛋白尿的有功能肾单位将会逐渐减少最终走向移植肾衰竭。蛋白尿影响移植肾长期有功能存活逐渐受到重视,关于肾移植受者蛋白尿有多个难题:①对于术前原肾尚有尿量伴有蛋白尿的患者,术后蛋白尿究竟来自原肾还是移植肾? 展开更多
关键词 肾移植受者 蛋白尿 生机 慢性肾脏疾病 肾移植术后 功能肾单位 功能存活 移植肾
原文传递
全国第二次器官移植学术会议
9
作者 董偃琴 《中华医学信息导报》 1994年第1期4-4,共1页
中华医学会器官移植学会第二次全国学术会议于1993年10月22~24日在武汉召开。来自全国26个省,自治区、直辖市的150代表参加了会议。澳大利亚、日本、美国等国外专家学者出席会议并作了报告。大会共收到241篇论文,其中大会发言15篇,小... 中华医学会器官移植学会第二次全国学术会议于1993年10月22~24日在武汉召开。来自全国26个省,自治区、直辖市的150代表参加了会议。澳大利亚、日本、美国等国外专家学者出席会议并作了报告。大会共收到241篇论文,其中大会发言15篇,小会发言151篇。陆道培、夏穗生、谢桐、管德林教授分别作了有关骨髓移植、肝移植、肾移植及第十四届国际器官移植学术会议的专题报告。 展开更多
关键词 器官移植 学术会议 肾移植 心脏移植 骨髓移植 肝移植 血友病甲 活体供脾 中华医学会 功能存活
原文传递
Influence of buccal acupuncture on analgesic effect,immune indicators,and expression of Survivin and Livin proteins in patients with advanced-stage primary liver cancer 被引量:3
10
作者 LIN Zhiguang SU Shengxian +3 位作者 XIE Xiaoli YANG Yuanfeng DONG Qinglong KONG Xiehe 《Journal of Acupuncture and Tuina Science》 CSCD 2022年第5期383-391,共9页
Objective To investigate the effects of buccal acupuncture on analgesia,immune indicators,and expression levels of Survivin and Livin proteins in patients with advanced-stage primary liver cancer.Methods Eighty patien... Objective To investigate the effects of buccal acupuncture on analgesia,immune indicators,and expression levels of Survivin and Livin proteins in patients with advanced-stage primary liver cancer.Methods Eighty patients with advanced-stage primary liver cancer were selected and divided into control and treatment groups according to the difference in treatment modalities,with 40 patients in each group.The control group received transcatheter arterial chemoembolization(TACE),and the treatment group received buccal acupuncture in addition to TACE.The recent efficacy,analgesic effect,liver function,serum tumor markers,Survivin and Livin protein expression levels in liver cancer tissue,and immune indexes were analyzed and compared between the two groups.Results The objective response rate(ORR)and disease control rate(DCR)of the treatment group were 37.5%and 77.5%,respectively,which were significantly higher than those of the control group(22.5%and 52.5%),and the recent efficacy of the treatment group was significantly better than that of the control group(P<0.05).The onset of analgesia in the treatment group was significantly faster than that in the control group(P<0.05),the duration of analgesia was significantly longer than that in the control group(P<0.05),and the numeric rating scale(NRS)score of pain after treatment was significantly lower than that in the control group(P<0.05).In the treatment group,the aspartate aminotransferase(AST),alanine aminotransferase(ALT),and albumin/globulin(A/G)were significantly lower than those in the control group(P<0.05),and the serum levels of alpha-fetoprotein(AFP),alpha-L-fucosidase(AFU),and carcinoembryonic antigen(CEA)were significantly lower than those in the control group(P<0.05),and the expression levels of Survivin and Livin in liver cancer tissue were significantly lower than those in the control group(P<0.05);CD4^(+)and CD4^(+)/CD8+in the treatment group were significantly higher than those in the control group,and CD8+was significantly lower than that in the control group after treatment(P<0.05).Conclusion Buccal acupuncture can reduce the degree of pain and liver function damage in patients with advanced-stage primary liver cancer and lower the serum tumor marker levels,and its mechanism of action may be related to the down-regulation of Survivin and Livin protein expression levels in the liver cancer tissue and the regulation of the immune function. 展开更多
关键词 Acupuncture Therapy Buccal Acupuncture Liver Neoplasms Acupuncture Analgesia Immune Function Liver Function Tests Biomarkers Tumor SURVIVIN
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部